An independent, not-for-profit projectFree knowledge. Better questions.
peptide.cyWhy we exist ↗
EVIDENCE GUIDE

From a promising molecule to a proven benefit

Mechanisms, biomarkers and patient outcomes answer different questions.

What it is

A cell experiment can reveal a mechanism. An animal study can test a hypothesis in a living system. Observational human data can find associations. Randomized trials can help determine treatment effects.

What the evidence tells us

Read the population, comparator, sample size, endpoint, follow-up and adverse events. An improvement in a biomarker may not improve symptoms, function or survival.

What remains uncertain

A small positive trial needs replication. Negative results matter. Avoid transferring findings between species, routes, sequences or formulations without supporting evidence.

Read the finding, not just the headline.

Check the population, product, route, comparator and outcome. A laboratory mechanism is not a proven health benefit, and a supplier’s certificate is not a clinical study.

Follow the evidence

Sources accessed 10 September 2026. Vendor claims and vendor-hosted reports are identified as such.

  1. Reynolds et al.: MOTS-c, exercise and muscle homeostasis ↗
  2. CJC-1295: human GH pulsatility study ↗
  3. Jastreboff et al.: phase 2 retatrutide trial ↗
Suggest a correction or missing study →

Keep your curiosity going.

Quality guide⟐Start here

99% pure. But pure of what? ↗

The number on the label is only one part of the evidence.

Read the evidence →
Quality guide⌬Practical checklist

How to read a peptide COA ↗

Follow the sample, the method and the evidence back to their source.

Read the evidence →
Quality guide∿Two different questions

Endotoxins ≠ sterility ↗

A product can pass one test and fail the other.

Read the evidence →

Put the evidence side by side.